Identification and Initial Validation of Neuroendocrine Differentiation as a Novel Prognostic Factor in Stage II Colorectal Cancer Patients
The prognosis of colorectal cancer with neuroendocrine differentiation (+) was poor, especially in stage II colorectal cancer patients. Neuroendocrine differentiation might be another high-risk factor for the prognosis of stage II colorectal cancer patients.
Authors
- Yongmin Li (ORCID: https://orcid.org/0000-0003-1668-2440)
- Yan Zhao (ORCID: https://orcid.org/0000-0002-5319-0202)
- Chang Hong (ORCID: https://orcid.org/0000-0001-5467-7226)
- Yue Chen (ORCID: https://orcid.org/0000-0003-0832-7801)
- Rui Guo (ORCID: https://orcid.org/0000-0002-6400-7098)
- Liang Yu (ORCID: https://orcid.org/0009-0001-5653-9991)
- Huanshuo Miao
Institutions
- Liaoning Cancer Hospital & Institute (CN)
- China Medical University (CN)
Publication Details
- Journal
- Oncology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1159/000540936
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00